IL141843A0 - Vaccine against sexually transmitted diseases - Google Patents

Vaccine against sexually transmitted diseases

Info

Publication number
IL141843A0
IL141843A0 IL14184399A IL14184399A IL141843A0 IL 141843 A0 IL141843 A0 IL 141843A0 IL 14184399 A IL14184399 A IL 14184399A IL 14184399 A IL14184399 A IL 14184399A IL 141843 A0 IL141843 A0 IL 141843A0
Authority
IL
Israel
Prior art keywords
vaccine against
sexually transmitted
transmitted diseases
against sexually
diseases
Prior art date
Application number
IL14184399A
Other languages
English (en)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL141843(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of IL141843A0 publication Critical patent/IL141843A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL14184399A 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases IL141843A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9819898A GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use
PCT/EP1999/006623 WO2000015255A1 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases

Publications (1)

Publication Number Publication Date
IL141843A0 true IL141843A0 (en) 2002-03-10

Family

ID=10838766

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14184399A IL141843A0 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases

Country Status (29)

Country Link
EP (1) EP1109574B1 (pt)
JP (1) JP2002524532A (pt)
KR (1) KR100777896B1 (pt)
CN (2) CN1325311A (pt)
AR (1) AR021798A1 (pt)
AT (1) ATE392214T1 (pt)
AU (1) AU744989B2 (pt)
BR (1) BR9913630A (pt)
CA (1) CA2343399C (pt)
CO (1) CO5090882A1 (pt)
CY (1) CY1108147T1 (pt)
CZ (1) CZ302808B6 (pt)
DE (1) DE69938555T2 (pt)
DK (1) DK1109574T3 (pt)
ES (1) ES2304068T3 (pt)
GB (1) GB9819898D0 (pt)
HK (1) HK1037978A1 (pt)
HU (1) HUP0104297A3 (pt)
IL (1) IL141843A0 (pt)
MY (1) MY122216A (pt)
NO (1) NO329522B1 (pt)
NZ (1) NZ510425A (pt)
PL (1) PL199545B1 (pt)
PT (1) PT1109574E (pt)
SI (1) SI1109574T1 (pt)
TR (1) TR200100948T2 (pt)
TW (1) TWI225790B (pt)
WO (1) WO2000015255A1 (pt)
ZA (1) ZA200101987B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2773698C (en) 1998-10-16 2015-05-19 Glaxosmithkline Biologicals S.A. Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
EP2360175B1 (en) 2005-11-22 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Norovirus and Sapovirus virus-like particles (VLPs)
CA2637598A1 (en) 2006-01-18 2007-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
RU2471497C2 (ru) 2007-09-12 2013-01-10 Новартис Аг Мутантные антигены gas57 и антитела против gas57
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
ES2596653T3 (es) 2009-06-16 2017-01-11 Glaxosmithkline Biologicals Sa Ensayos bactericidas de opsonización y dependientes de anticuerpo mediado por el complemento de alto rendimiento
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
EP3730943A1 (en) 2010-04-08 2020-10-28 University of Pittsburgh - Of the Commonwealth System of Higher Education B-cell antigen presenting cell assay
JP2013532008A (ja) 2010-05-28 2013-08-15 テトリス オンライン インコーポレイテッド 対話式ハイブリッド非同期コンピュータ・ゲーム・インフラストラクチャ
EP2726097A4 (en) 2011-07-01 2015-03-11 Univ California HERPES VIRUS VACCINE AND METHOD OF USE
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
EP4342545A3 (en) 2014-07-07 2024-06-26 Elian LLC Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
CA3010905A1 (en) 2016-02-22 2017-08-31 Boehringer Ingelheim Vetmedica Gmbh Method for the immobilization of biomolecules
WO2020086408A1 (en) 2018-10-26 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A high-yield perfusion-based transient gene expression bioprocess

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
SG48309A1 (en) * 1993-03-23 1998-04-17 Smithkline Beecham Biolog Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
CN101130070A (zh) 2008-02-27
DK1109574T3 (da) 2008-06-30
ES2304068T3 (es) 2008-09-01
PL346651A1 (en) 2002-02-25
DE69938555T2 (de) 2009-06-10
SI1109574T1 (sl) 2008-08-31
GB9819898D0 (en) 1998-11-04
EP1109574B1 (en) 2008-04-16
HUP0104297A2 (hu) 2002-03-28
AU744989B2 (en) 2002-03-07
TR200100948T2 (tr) 2001-07-23
HK1037978A1 (en) 2002-03-01
CN1325311A (zh) 2001-12-05
MY122216A (en) 2006-03-31
PT1109574E (pt) 2008-06-12
WO2000015255A1 (en) 2000-03-23
ATE392214T1 (de) 2008-05-15
CA2343399A1 (en) 2000-03-23
BR9913630A (pt) 2001-05-22
ZA200101987B (en) 2002-05-09
AU5975299A (en) 2000-04-03
NO329522B1 (no) 2010-11-01
CY1108147T1 (el) 2014-02-12
JP2002524532A (ja) 2002-08-06
CA2343399C (en) 2010-08-03
CZ302808B6 (cs) 2011-11-23
HUP0104297A3 (en) 2004-10-28
NZ510425A (en) 2003-04-29
KR100777896B1 (ko) 2007-11-27
EP1109574A1 (en) 2001-06-27
CO5090882A1 (es) 2001-10-30
KR20010075049A (ko) 2001-08-09
AR021798A1 (es) 2002-08-07
NO20011193L (no) 2001-05-09
DE69938555D1 (de) 2008-05-29
TWI225790B (en) 2005-01-01
PL199545B1 (pl) 2008-09-30
NO20011193D0 (no) 2001-03-08
CZ2001887A3 (cs) 2001-10-17

Similar Documents

Publication Publication Date Title
HUP0100763A3 (en) Antibodies against human cd40
IL158107A0 (en) Human papillomaviruses vaccine
HUP0103976A3 (en) Novel methods for therapeutic vaccination
IL140094A0 (en) Vaccine
PL346651A1 (en) Vaccine against sexually transmitted diseases
HUP0104842A3 (en) Vaccine
SI1117421T1 (en) Methods for therapeutic vaccination
GB9807805D0 (en) Vaccine
GB9820956D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9802543D0 (en) Vaccine
GB9805961D0 (en) Vaccine
GB9828035D0 (en) Vaccine
GB9822709D0 (en) Vaccine
GB9822703D0 (en) Vaccine
GB9812773D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9811954D0 (en) Vaccine
GB9802544D0 (en) Vaccine
GB9807933D0 (en) Vaccine
GB9806765D0 (en) Vaccine
GB9805962D0 (en) Vaccine
GB9822712D0 (en) Vaccine
GB9805960D0 (en) Vaccine
GB9802650D0 (en) Vaccine

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees